Whenever you come across Renovia, the mention of Marc Beer is almost guaranteed. While you are pondering why the reason is simple, Marc Beer is Renovia’s current (CEO) chief executive officer and also the firm’s Co-Founder. Renovia is a healthcare Start-up that was established in 2016 and has been in operation for over two years.
A talk about serial healthcare entrepreneurs who are highly successful can’t end with the mention of Marc Beer. Other than being an entrepreneur invested in the healthcare industry thanks to his participation in the formation of several healthcare start-ups such as ViaCell and LumeNXT, Marc Beer is a renowned business executive credited with steering various firm to success. If you want to find more information on Marc Beer, visit the link we have shared; https://www.linkedin.com/in/marcbeer.
Renovia has its headquarters in Boston, United States. The firm’s primary objective since inception has been to provide a solution for pelvic floor disorder; a condition that affects millions of women across the globe. Women affected by this condition have challenges controlling the pelvic floor muscle; this results in the inability to control the release of bowels.
While it is accurate to say that Renovia is still a young firm since it has been around the block for just two years, the new kid on the block has made excellent achievements in the two years of its existence. The firm recently released a product known as Leva device into the market.
The Leva device has been designed to aid in the treating of the pelvic floor disorder, and practitioners and individuals using it can attest to its efficiency in serving its purpose. Besides, the FDA has approved the use of the Leva device. Besides overseeing the design, development, and release of the Leva device, Marc Beer can also be credited for completing Renovia’s Series B funding.
Reports show that Renovia raised $42 million during its Series B funding. Estimates show that $10 million was of the Series B funding was raised through venture debt. Renovia intends to use the funds raised through the Series B funding for the development of new products. Since Renovia as a firm doesn’t enjoy a market monopoly, it is expected that the funding will also be used for commercial campaigns and corporate development.
While Renovia’s Series B funding was a success thanks to the efforts of several key players, the firm’s three longstanding partners played a significant role in ensuring that the Series B funding would be a success just like the Series A funding. Renovia’s longstanding partners include Perceptive Advisors, Longwood Funds, and Ascension Ventures. These three firms played a critical role in ensuring Series A funding was a success. Learn more: https://patch.com/massachusetts/boston/renovias-marc-beer-raises-42m-treat-womens-health-issues